Terms: = Bone cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Diagnosis
6 results:
1. Hypoxia-mediated changes in bone marrow microenvironment in breast cancer dormancy.
Ferrer A; Roser CT; El-Far MH; Savanur VH; Eljarrah A; Gergues M; Kra JA; Etchegaray JP; Rameshwar P
Cancer Lett; 2020 Sep; 488():9-17. PubMed ID: 32479768
[TBL] [Abstract] [Full Text] [Related]
2. Expression significance and potential mechanism of hypoxia-inducible factor 1 alpha in patients with myelodysplastic syndromes.
Liang HW; Luo B; Du LH; He RQ; Chen G; Peng ZG; Ma J
Cancer Med; 2019 Oct; 8(13):6021-6035. PubMed ID: 31411003
[TBL] [Abstract] [Full Text] [Related]
3. Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Krawczyk MA; Styczewska M; Sokolewicz EM; Kunc M; Gabrych A; Fatyga A; Izycka-Swieszewska E; Kazanowska B; Adamkiewicz-Drozynska E; Bien E
Biomarkers; 2019 Sep; 24(6):538-548. PubMed ID: 30995126
[No Abstract] [Full Text] [Related]
4. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
[TBL] [Abstract] [Full Text] [Related]
5. HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target.
Ria R; Catacchio I; Berardi S; De Luisi A; Caivano A; Piccoli C; Ruggieri V; Frassanito MA; Ribatti D; Nico B; Annese T; Ruggieri S; Guarini A; Minoia C; Ditonno P; Angelucci E; Derudas D; Moschetta M; Dammacco F; Vacca A
Clin Cancer Res; 2014 Feb; 20(4):847-58. PubMed ID: 24297864
[TBL] [Abstract] [Full Text] [Related]
6. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma.
Maroni P; Matteucci E; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
Breast Cancer Res Treat; 2011 Sep; 129(2):433-50. PubMed ID: 21069452
[TBL] [Abstract] [Full Text] [Related]
